Close Menu

The Indian pharmaceutical sector "was once notorious for making cheap knockoffs of Western medicines" to sell in developing countries, says the New York Times, but now it is a manufacturing center of drugs to sell worldwide. "What I see happening now is manufacturing and even packaging and even formulation are moving to India," says Jim Worrell, the chief executive of Pharma Services Network.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.